Patent · US Active

Binding agents

US11939372B2 · kind B2 · utility

0Cited by
74References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 23, 2019
Grant dateMar 26, 2024
Priority date
Expiry dateOct 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.